Resultados de la búsqueda 91-100 of 11106 for monoclonal antibody

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...